Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A formulation and granule technology, which is applied in the direction of pharmaceutical formulations, medical preparations containing active ingredients, bulk delivery, etc., to achieve the effects of avoiding early maturation, delaying premature development, delaying closure time and ovarian ovulation time
Inactive Publication Date: 2021-10-19
杨丽珍
View PDF1 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, for the treatment of this type of syndrome, most doctors in modern medicine cannot accurately differenti
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0017] Such as figure 1 As shown, the present invention provides a Zhizao granule formula, the crude drug amount of the formula is: Bupleurum 6g, Gardenia 10g, Scutellaria baicalensis 10g, Cortex Moutan 6g, Curcuma 10g, Rhizoma Cyperi 10g, Trichosanthes 10g, Prunella vulgaris 10g, Fritillaria 10g, litchi core 10g, Atractylodes macrocephala 10g, tangerine peel 6g, pinellia chinensis 6g and peony root 10g.
Embodiment 2
[0019] Such as figure 1 As shown, the present invention provides a Zhizao granule formula, and the crude drug amount of the formula is: Bupleurum 3g, Gardenia 7g, Scutellaria baicalensis 7g, Moutan cortex 3g, Curcuma 7g, Cyperus cyperi 7g, Trichosanthes 7g, Prunella vulgaris 7g, Fritillaria 7g, litchi core 7g, Atractylodes macrocephala 7g, tangerine peel 3g, pinellia chinensis 3g and peony root 7g.
Embodiment 3
[0021] Such as figure 1 As shown, the present invention provides a Zhizao granule formula, the crude drug amount of the formula is: Bupleurum 9g, Gardenia 13g, Scutellaria baicalensis 13g, Cortex Moutan 9g, Curcuma 13g, Rhizoma Cyperi 13g, Trichosanthes 13g, Prunella vulgaris 13g, Fritillaria 13g, litchi core 13g, Atractylodes macrocephala 13g, tangerine peel 9g, pinellia 9g and peony root 13g.
[0022] Specifically, Bupleurum relieving stagnation of the liver, and gardenia clearing away the liver-fire, so that the liver-qi can be organized and the pent-fire can be cleared, and they are the king medicines. Scutellaria baicalensis is bitter and cold, clearing heat and purging fire; Cortex Moutan cools blood and activates blood; Curcuma returns to liver, gallbladder, and heart meridian, regulates qi and activates blood, soothes liver and relieves stagnation; Rhizoma cyperus can circulate qi, dissolve six stagnations, and enter the blood Divide, clear the veins; all medicines ar...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a formula of gardenia jasminoides granules. The formula comprises the following raw medicinal materials: 3 to 9 grams of radix bupleuri, 7 to 13 grams of fructus gardeniae, 7 to 13 grams of radix scutellariae, 3 to 9 grams of cortex moutan, 7 to 13 grams of radix curcumae, 7 to 13 grams of rhizoma cyperi, 7 to 13 grams of fructus trichosanthis, 7 to 13 grams of spica prunellae, 7 to 13 grams of bulbus fritillariae thunbergii, 7 to 13 grams of semen litchi, 7 to 13 grams of rhizoma atractylodis macrocephalae, 3 to 9 grams of pericarpium citri reticulatae, 3 to 9 grams of rhizoma pinelliae preparata and 7 to 13 grams of radix paeoniae alba. The formula of the gardenia jasminoides granules can be used for treating idiopathic central precocious puberty, delaying premature development of a second sexual character and avoiding early maturity of bones and sexual organs, so that the treatment purposes of delaying the closing time of epiphysis and ovulation time of ovaries and improving the expected height and fertility function of sick children are achieved.
Description
technical field [0001] The invention relates to the field of pharmaceutical formulations, in particular to a formulation of Zhizao granules. Background technique [0002] Precocious puberty refers to the appearance of secondary sexual characteristics before the age of 8 in girls and 9 years in boys. In recent years, with the improvement of material life and nutritional conditions, and the aggravation of chemical pollution, the clinical incidence of precocious puberty has increased year by year. It is a frequently-occurring disease and a common disease in children's endocrinology. Idiopathic central precocious puberty is a common type of precocious puberty, with an incidence of more than 92% of all precocious children. The main hypothalamus-pituitary-gonadal axis is prematurely activated, and the secretion of gonadotropin-releasing hormone pulses is enhanced, stimulating The synthesis and release of follicle-stimulating hormone and luteinizing hormone, FSH and LH stimulate t...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more